MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about board meeting

05 Feb 2022 Evaluate

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Ambalal Sarabhai Enterprises has informed the exchange that a meeting of the Board of Directors of the Company is scheduled to be held on Monday, February 14, 2022, to transact the following: To consider and approve the Un-audited Financial Results (Standalone & Consolidated) of the Company for the Quarter and nine months ended December 31,2021 and Any other matter as the Board of Directors of the Company may decide during the course of the Meeting. Further, in continuation of its intimation dated December 31,2021 and pursuant to Company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons and their Immediate Relatives, the trading window for dealing in the securities of the Company is closed from January 1,2022 to February 16, 2022.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..